Saturday 17 October 2026
Export MYO’s income statement to Excel — free account
Myomo, Inc.
MYO Healthcare Medical Devices
Myomo, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $40.9 million, up 25.7% from fiscal 2024. In the quarter to June 2026, revenue grew 21.3%, EPS grew 18.2%, free cash flow grew 80.0% and total debt rose 199.5%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.
1.20
0.10
−7.69%
Follow MYO
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 5 | 5 | 3 | 4 | 6 | 2 | 5 | 4 | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(3.04) | 5.83 | 6.68 | (12.93) | (0.44) | (3.06) | (15.68) | (4.96) | 2.47 | — |
P/S ratio |
0.93 | 7.47 | 7.34 | 0.24 | 2.88 | 2.96 | 1.30 | 7.25 | 10.10 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(8.82) | (3.95) | (20.10) | (30.16) | (7.81) | (10.77) | (36.07) | (17.97) | 3.04 | (66.36) |
P/Operating CF |
(33.40) | 72.25 | (59.98) | (1.49) | (21.84) | (19.42) | (1.89) | (7.05) | (10.21) | (7.17) |
Beneish M-Score |
(2.81) | (0.88) | (2.99) | (2.44) | (0.93) | (2.38) | (2.90) | (0.47) | (3.38) | (2.72) |
P/B ratio |
3.34 | 9.84 | 15.72 | 0.58 | 2.59 | 1.94 | 2.74 | 2.76 | 1.27 | 0.00 |
Price to Tangible BV |
3.34 | 9.84 | 15.72 | 0.58 | 2.59 | 1.94 | 2.74 | 2.76 | 1.27 | 0.00 |
EV/Sales |
0.79 | 6.73 | 6.92 | (0.07) | 1.81 | 1.36 | 0.83 | 5.10 | 2.62 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(2.24) | (66.57) | (21.57) | 0.11 | (2.63) | (1.14) | (0.31) | (1.30) | (0.66) | (2.01) |
EV/FCF |
(1.82) | (47.10) | (21.07) | 0.11 | (2.55) | (1.14) | (0.31) | (1.28) | (0.66) | (2.01) |
Quick Ratio |
2.69 | 2.82 | 2.05 | 2.01 | 4.08 | 4.59 | 1.26 | 3.73 | 8.93 | 0.30 |
Current Ratio |
3.30 | 3.22 | 2.49 | 2.56 | 4.46 | 5.03 | 1.58 | 4.24 | 9.32 | 0.38 |
Net Debt/EBITDA |
0.60 | 4.52 | 1.13 | 0.51 | 1.52 | 1.18 | 0.17 | 0.63 | 1.99 | (0.79) |
Debt/Assets |
29.05% | 0.00% | 0.00% | 1.97% | 2.00% | 1.05% | 40.20% | 0.00% | 0.00% | 204.08% |
Debt/Equity |
0.98 | 0.00 | 0.00 | 0.03 | 0.03 | 0.01 | 1.45 | 0.00 | 0.00 | (0.70) |
Asset Turnover |
1.01 | 1.15 | 1.56 | 1.03 | 0.80 | 0.71 | 0.52 | 0.22 | 0.20 | 0.70 |
Operating CF/Net income |
0.93 | 0.53 | 0.76 | 0.95 | 0.87 | 0.74 | 0.90 | 0.93 | 0.49 | 0.73 |
Capex/Depreciation |
(1.36) | (1.94) | (0.36) | (0.21) | (0.97) | (0.17) | (0.34) | (1.82) | (2.29) | (0.14) |
Interest Coverage |
— | — | — | (120.32) | (671.12) | (22.12) | (95.96) | 60.03 | (18.24) | (9.58) |
| (86.24%) | (36.69%) | (106.17%) | (98.50%) | (81.65%) | (182.74%) | (279.03%) | (109.34%) | 497.94% | 27.90% | |
| (38.51%) | (21.76%) | (65.86%) | (70.87%) | (63.28%) | (114.83%) | (154.71%) | (92.71%) | (161.95%) | (276.84%) | |
ROIC |
(212.70%) | 0.00% | (4,169.11%) | (549.61%) | (2,241.55%) | 0.00% | (55,759.30%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(72.69%) | (25.82%) | (97.58%) | (184.59%) | (73.01%) | (104.83%) | (475.45%) | (166.23%) | (101.78%) | 239.15% |
Average Days of Receivables |
36.53 | 42.89 | 45.20 | 44.49 | 51.63 | 44.52 | 40.35 | 57.09 | 69.54 | 37.88 |
Research and Development Expense of Revenue |
16.97% | 14.66% | 13.70% | 15.96% | 18.46% | 22.01% | 45.59% | 75.23% | 112.37% | 101.60% |
Selling, General and Administrative Expense of Revenue |
83.92% | 75.63% | 97.59% | 118.56% | 130.07% | 182.19% | 298.68% | 425.74% | 375.26% | 269.66% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
5.09% | 2.69% | 5.80% | 7.65% | 7.91% | 8.10% | 23.66% | 33.33% | 19.98% | 8.53% |
Graham Net Nets |
0.01 | 0.06 | 0.06 | 1.48 | 0.36 | 0.50 | 0.28 | 0.34 | 0.78 | 0.16 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(40.66%) | (2.64%) | (5.85%) | (292.31%) | (27.88%) | (69.84%) | (212.89%) | (58.39%) | (142.43%) | (59.04%) |
Free Cash Flow Yield |
(46.85%) | (1.91%) | (4.47%) | (282.16%) | (24.73%) | (40.51%) | (207.77%) | (54.95%) | (39.50%) | (52.39%) |
Revenue per Share |
0.98 | 0.86 | 0.65 | 2.21 | 2.38 | 2.28 | 6.93 | 5.96 | 10.84 | 31.26 |
Operating CF per Share |
(0.35) | (0.09) | (0.21) | (1.45) | (1.64) | (2.71) | (18.67) | (23.43) | (42.79) | (90.73) |
Capex per Share |
(0.08) | (0.04) | 0.00 | (0.02) | (0.06) | (0.01) | (0.09) | (0.31) | (0.47) | (0.05) |
Free Cash Flow per Share |
(0.43) | (0.12) | (0.21) | (1.47) | (1.69) | (2.73) | (18.76) | (23.74) | (43.26) | (90.78) |
Cash per Share |
0.44 | 0.66 | 0.30 | 0.76 | 2.66 | 3.68 | 8.06 | 15.95 | 90.12 | 22.58 |
Shareholders Equity per Share |
0.27 | 0.65 | 0.30 | 0.90 | 2.64 | 3.47 | 3.29 | 15.67 | 86.55 | (137.63) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.27 | 0.65 | 0.30 | 0.90 | 2.64 | 3.47 | 3.29 | 15.67 | 86.55 | (137.63) |
Free Cash Flow |
(17.84) | (4.65) | (6.32) | (10.35) | (9.87) | (9.08) | (10.39) | (9.73) | (6.22) | (3.20) |
Working Capital |
19.21 | 22.62 | 8.17 | 5.61 | 14.81 | 11.58 | 2.27 | 6.02 | 12.36 | (1.85) |
Capital Expenditures |
(3.33) | (1.36) | (0.15) | (0.11) | (0.33) | (0.05) | (0.05) | (0.13) | (0.07) | 0.00 |
Net Current Asset Value |
0.32 | 15.26 | 8.06 | 5.41 | 14.41 | 11.30 | 1.38 | 6.02 | 12.32 | (5.37) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.08 | 0.04 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.05 | 0.04 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.11 | 0.53 | 2.31 | 2.79 | 1.22 | 2.85 | 0.99 | 0.37 | 0.38 | 0.61 |
Cash ROIC |
(43.50%) | (9.38%) | (35.39%) | (86.89%) | (31.51%) | (37.89%) | (116.22%) | (75.06%) | (24.48%) | 473.49% |
Accounts Receivable Turnover |
10.33 | 10.49 | 8.99 | 8.07 | 9.61 | 11.24 | 9.52 | 7.20 | 7.58 | 9.59 |
Accounts Payable Turnover |
1.89 | 1.35 | 1.50 | 1.50 | 1.05 | 1.13 | 0.82 | 0.48 | 0.51 | 0.53 |
Inventory Turnover |
4.46 | 3.77 | 3.78 | 4.80 | 4.68 | 4.54 | 4.09 | 3.19 | 3.56 | 3.13 |
Average Days of Payables |
151.30 | 351.59 | 294.34 | 218.87 | 402.75 | 399.88 | 446.62 | 873.73 | 922.58 | 923.49 |
Days of Inventory on Hand |
81.19 | 123.38 | 108.65 | 96.37 | 83.25 | 99.25 | 112.91 | 128.35 | 145.34 | 106.58 |
Average Receivables |
3.96 | 3.10 | 2.14 | 1.93 | 1.44 | 0.67 | 0.40 | 0.34 | 0.21 | 0.12 |
Average Payables |
7.42 | 6.95 | 4.03 | 3.55 | 3.38 | 2.29 | 1.74 | 1.51 | 1.00 | 0.53 |
Average Inventory |
3.14 | 2.48 | 1.60 | 1.10 | 0.76 | 0.57 | 0.35 | 0.23 | 0.14 | 0.09 |
Average Assets |
40.44 | 28.41 | 12.37 | 15.13 | 17.40 | 10.65 | 7.44 | 11.13 | 7.82 | 1.58 |
Average Common Equity |
18.06 | 16.85 | 7.67 | 10.88 | 13.49 | 6.70 | 4.13 | 9.44 | (2.54) | (15.72) |
Columns are period end dates